货号:A982362
                
                同义名:
                    
                        
                            脱甲氧姜黄
                            
                             / Curcumin II; Desmethoxycurcumin
                            
                        
                    
                
                
                
                    
                    
                    
                    
                
            
Demethoxycurcumin是一种主要的活性姜黄素类物质,具有抗炎特性,并通过诱导细胞凋亡对人类癌细胞表现出细胞毒性作用。
                                
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | 
                                     {[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | 
                                
                                     {[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | 
                                {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
                        
                    
| 产品名称 | AChE ↓ ↑ | AChR ↓ ↑ | mAChR ↓ ↑ | nAChR ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Donepezil | 
                                                
                                                    +++
                                                    
                                                    
                                                     bAChE, IC50: 8.12 nM hAChE, IC50: 11.6 nM  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Loganin | 
                                                
                                                    ++
                                                    
                                                    
                                                     AChE, IC50: 3.95 μM  | 
                                            
                                        
                                            
                                            99%+ | |||||||||||||||||
| topride HCl | 
                                                
                                                    ++
                                                    
                                                    
                                                     AChE, IC50: 2.04 μM  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Dehydroevodiamine HCl | ✔ | 99%+ | |||||||||||||||||
| Jatrorrhizine | 
                                                
                                                    ++
                                                    
                                                    
                                                     AChE, IC50: 872 nM  | 
                                            
                                        
                                            
                                            99%+ | |||||||||||||||||
| Palmatine | 
                                                
                                                    ++
                                                    
                                                    
                                                     AChE, IC50: 0.51 μM  | 
                                            
                                        
                                            
                                            95% | |||||||||||||||||
| (-)-Huperzine A | 
                                                
                                                    ++++
                                                    
                                                    
                                                     AChE (G4 form), Ki: 7 nM  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Galanthamine HBr | 
                                                
                                                    ++
                                                    
                                                    
                                                     AChE, IC50: 0.35 μM  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Trospium chloride | ✔ | 99% | |||||||||||||||||
| Tiotropium Bromide Monohydrate | ✔ | 97% | |||||||||||||||||
| Gallamine Triethiodide | 
                                                
                                                    +
                                                    
                                                    
                                                     AChR, IC50: 68.0 μM  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Hexamethonium Bromide | ✔ | 99% | |||||||||||||||||
| Pancuronium dibromide | ✔ | 98% | |||||||||||||||||
| Neostigmine bromide | ✔ | 98% | |||||||||||||||||
| Orphenadrine citrate | ✔ | 98% | |||||||||||||||||
| Oxybutynin | ✔ | 98% | |||||||||||||||||
| Irsogladine | ✔ | PDE | 99% | ||||||||||||||||
| Pyridostigmine bromide | ✔ | 99+% | |||||||||||||||||
| Rivastigmine | 
                                                
                                                    +
                                                    
                                                    
                                                     AChR, IC50: 5.5 μM  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Paroxetine HCl | ✔ | 99% | |||||||||||||||||
| Rocuronium Bromide | ✔ | 98% | |||||||||||||||||
| Tropicamide | 
                                                
                                                    +++
                                                    
                                                    
                                                     M4 mAChR, IC50: 8 nM  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Diphenmanil methylsulfate | ✔ | 97% | |||||||||||||||||
| Umeclidinium bromide | ✔ | 95% | |||||||||||||||||
| Otilonium bromide | ✔ | 98% | |||||||||||||||||
| Flavoxate HCl | 
                                                
                                                    +
                                                    
                                                    
                                                     mAChR, IC50: 12.2 μM  | 
                                            
                                        
                                            
                                            99% | |||||||||||||||||
| Ipratropium bromide | ✔ | 98% | |||||||||||||||||
| Diphenidol HCl | ✔ | 98% | |||||||||||||||||
| Darifenacin hydrobromide | 
                                                
                                                    ++++
                                                    
                                                    
                                                     M3 mAChR, pKi: 8.9  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Aclidinium Bromide | 
                                                
                                                    ++++
                                                    
                                                    
                                                     M4 mAChR, Ki: 0.21 nM M2 mAChR, Ki: 0.1 nM  | 
                                            
                                        
                                            
                                            98% | |||||||||||||||||
| Oxybutynin chloride | ✔ | 99% | |||||||||||||||||
| Pentoxyverine citrate | ✔ | 98% | |||||||||||||||||
| Solifenacin | ✔ | 98% | |||||||||||||||||
| Catharanthine | ✔ | 98% | |||||||||||||||||
| Benzethonium chloride | 
                                                
                                                    +++
                                                    
                                                    
                                                     α4β2 nAChRs, IC50: 49 nM α7 nAChRs, IC50: 122 nM  | 
                                            
                                        
                                        99+% | |||||||||||||||||
| Vinblastine sulfate | 
                                                
                                                    +
                                                    
                                                    
                                                     nAChR, IC50: 8.9 μM  | 
                                            
                                        
                                        99% | |||||||||||||||||
| PNU-120596 | 
                                                
                                                    ++
                                                    
                                                    
                                                     α7 nAChR, EC50: 216 nM  | 
                                            
                                        
                                        99+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | Autophagy ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBI-0206965 | 
                                                
                                                    +++
                                                    
                                                    
                                                     ULK1, IC50: 108 nM ULK2, IC50: 711 nM  | 
                                            
                                        
                                        95% | |||||||||||||||||
| Hydroxychloroquine sulfate | ✔ | 99% | |||||||||||||||||
| Valproic acid sodium | ✔ | HDAC | 97% | ||||||||||||||||
| PFK-015 | 
                                                
                                                    ++
                                                    
                                                    
                                                     PFKFB3, IC50: 207 nM  | 
                                            
                                        
                                        99%+ | |||||||||||||||||
| MRT68921 HCl | 
                                                
                                                    ++++
                                                    
                                                    
                                                     ULK1, IC50: 2.9 nM ULK2, IC50: 1.1 nM  | 
                                            
                                        
                                        99%+ | |||||||||||||||||
| ROC-325 | ✔ | 99%+ | |||||||||||||||||
| Autophinib | 
                                                
                                                    +++
                                                    
                                                    
                                                     Autophagy, IC50: 40 nM  | 
                                            
                                        
                                        99% | |||||||||||||||||
| Lys05 | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Monodemethoxycurcumin (demethoxycurcumin) is a major active curcuminoid and possess anti-inflammatory properties and also exert cytotoxic effects in human cancer cells via induction of apoptosis. DMC (demethoxycurcumin) significantly decreased NO secretion by 35-41% in our inflamed cell model[3]. Genes associated with DNA damage and repair, cell-cycle check point and apoptosis could be altered by DMC; in particular, 144 genes were found up-regulated and 179 genes down-regulated in NCI-H460 cells after exposure to DMC[4]. Administration of DMC to PD rats eased the protein expression of dopaminergic and apoptotic indices[5]. DMC significantly reduced tumor weights and volumes of HeLa cell xenografts in mice, indicating the suppression of growth of xenograft tumors[6]. | 
| Concentration | Treated Time | Description | References | |
| BEAS-2B cells | 1-4 μg/mL | 48 h | To study the effect of demethoxycurcumin on normal bronchial epithelial cells BEAS-2B, results showed no effect on cell growth. | Int J Nanomedicine. 2015 Aug 5;10:5059-80 | 
| H460 cells | 2-6 μg/mL | 24-48 h | To study the inhibitory effect of demethoxycurcumin on H460 cells, results showed H460 cells were more susceptible to apoptosis than A549 cells. | Int J Nanomedicine. 2015 Aug 5;10:5059-80 | 
| A549 cells | 2-6 μg/mL | 24-48 h | To study the inhibitory effect of demethoxycurcumin on A549 cells, results showed cell cycle arrest at G2/M phase and induction of apoptosis. | Int J Nanomedicine. 2015 Aug 5;10:5059-80 | 
| SH-SY5Y cells | 1 µM | 24 h | Evaluate the protective effect of demethoxycurcumin against Aβ42-induced neurotoxicity, results showed demethoxycurcumin protected 50-60% of cells from Aβ42-induced cell death | Antioxidants (Basel). 2021 Oct 11;10(10):1592 | 
| N2a cells | 1 µM | 24 h | Evaluate the protective effect of demethoxycurcumin against Aβ42-induced neurotoxicity, results showed demethoxycurcumin protected 50-60% of cells from Aβ42-induced cell death | Antioxidants (Basel). 2021 Oct 11;10(10):1592 | 
| HeLa cells | 10 µM | 24 h | Evaluate the effect of demethoxycurcumin on histone H3 citrullination in various cancer cells | Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220248 | 
| A375 cells | 10 µM | 24 h | Evaluate the effect of demethoxycurcumin on histone H3 citrullination in various cancer cells | Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220248 | 
| SK-OV-3 cells | 10 µM | 24 h | Evaluate the effect of demethoxycurcumin on histone H3 citrullination in various cancer cells | Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220248 | 
| A549 cells | 10 µM | 24 h | Evaluate the effect of demethoxycurcumin on endogenous histone H3 citrullination | Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220248 | 
| HEK293T cells | 10 µM | 24 h | Evaluate the effect of demethoxycurcumin on histone H3 citrullination in PAD2-overexpressing cells | Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220248 | 
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | GBM 8401/luc2 cell xenograft tumor model | Oral gavage | 30 mg/kg and 60 mg/kg | Once daily for 21 days | DMC significantly inhibited tumor volume and weight growth, with 60 mg/kg showing higher efficacy than 30 mg/kg, without affecting body weight or causing liver toxicity | Int J Mol Sci. 2021 May 23;22(11):5503 | 
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 | 
| NCT01982734 | Pharmacokinetics of New Curcum... 展开 >>in Formulations Safety of New Curcumin Formulations 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << | 
| NCT01330810 | Comparative Multidose Pharmaco... 展开 >>kinetics 收起 << | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> UNC Department of Family Medicine Chapel Hill, North Carolina, United States, 27599 收起 << | 
| NCT03621865 | Healthy | Not Applicable | Completed | - | France ... 展开 >> Biofortis Mérieux NutriSciences Saint-Herblain, France, 44800 收起 << | 
| 计算器 | ||||
| 存储液制备 | ![]()  | 
                        1mg | 5mg | 10mg | 
| 
                             1 mM 5 mM 10 mM  | 
                        
                             2.96mL 0.59mL 0.30mL  | 
                        
                             14.78mL 2.96mL 1.48mL  | 
                        
                             29.56mL 5.91mL 2.96mL  | 
                    |
| CAS号 | 22608-11-3 | 
| 分子式 | C20H18O5 | 
| 分子量 | 338.35 | 
| SMILES Code | O=C(CC(/C=C/C1=CC=C(O)C=C1)=O)/C=C/C2=CC=C(O)C(OC)=C2 | 
| MDL No. | MFCD03427310 | 
| 别名 | 脱甲氧姜黄 ;Curcumin II; Desmethoxycurcumin; DMC; Monodemethoxycurcumin | 
| 运输 | 蓝冰 | 
| 存储条件 | 
                                
                                    
                                             In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C  | 
                        
| 溶解方案 | 
                                
                                    
                                     DMSO: 105 mg/mL(310.33 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
  | 
                        
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1